Navarro, F.
Martinez-Sesmero, J. M.
Balsa, A.
Peral, C.
Montoro, M.
Valderrama, M.
Gómez, S.
de Andrés-Nogales, F.
Casado, M. A.
Oyagüez, Itziar http://orcid.org/0000-0002-3047-6152
Funding for this research was provided by:
Pfizer Spain (Pfizer-2019-11)
Article History
Received: 3 March 2020
Revised: 1 April 2020
Accepted: 2 April 2020
First Online: 17 April 2020
Compliance with ethical standards
:
: FdA, MAC and IO are employed by Pharmacoeconomics & Outcomes Research Iberia (PORIB), a consulting company specialised in the economic evaluation of health interventions which received funding from Pfizer to carry out this work.FN, JMMS, AB have received honoraries from Pfizer to be part of the advisory board which validated the project.CP, MM, SG and MV are Pfizer employees (Spain).
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.